Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer-Reference-Cited by-同舟云学术

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer

Published:2015-05-09 Issue:8 Volume:64 Page:977-987
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Balint Joseph P.,Gabitzsch Elizabeth S.,Rice Adrian,Latchman Yvette,Xu Younong,Messerschmidt Gerald L.,Chaudhry Arvind,Morse Michael A.,Jones Frank R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1706-4.pdf

Reference44 articles.

1. Vergati M, Intrivici C, Huen N-Y, Schlom J, Tsang KY (2010) Strategies for cancer vaccine development. J Biomed Biotechnol. doi: 10.1155/2010/596432

2. Palena C, Schlom J (2010) Vaccines against human carcinomas: strategies to improve antitumor immune responses. J Biomed Biotechnol. doi: 10.1155/2010/380697

3. Schlom J (2012) Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst 104:599–613

4. Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10:616–629

5. Bangari DS, Mittal SK (2006) Development of nonhuman adenoviruses as vaccine vectors. Vaccine 24:849–862

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Vaccine Therapy for Triple-Negative Breast Cancer;Current Breast Cancer Reports;2024-05-08

2. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy;Frontiers in Immunology;2024-03-12

3. Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor by reducing the immunosuppressive tumor microenvironment in a colorectal cancer model;2024-02-29

4. VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial;Journal for ImmunoTherapy of Cancer;2024-01

5. Viral vector‐based cancer treatment and current clinical applications;MedComm – Oncology;2023-10-29